Literature DB >> 24878397

[Extravasation of contrast media at the puncture site: Strategies for managment].

F J Pacheco Compaña1, B Gago Vidal1, C Méndez Díaz2.   

Abstract

The incidence of contrast medium extravasation at the venipuncture site has increased with the generalized use of automatic injectors. Most extravasations only cause slight edema and erythema. Nevertheless, in some cases extravasation can result in severe skin lesions or even in compartment syndrome. Lesions caused by extravasation usually resolve spontaneously with conservative treatment. Although the complications of extravasation are well known, institutional protocols are normally lacking and the criteria for taking action and the type of treatment, whether based on the literature or personal preferences, tend to vary. In this article, we review the incidence, risk factors, clinical manifestations, and options for preventing and treating contrast medium extravasation in soft tissues. Finally, we present the protocol we use to manage extravasation at our hospital.
Copyright © 2013 SERAM. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Contrast media; Extravasación de materiales diagnósticos y terapéuticos; Extravasation of diagnostic and therapeutic material; Manejo seguro de la extravasación de medios de contraste; Medios de contraste; Safe management of contrast medium extravasation

Mesh:

Year:  2014        PMID: 24878397     DOI: 10.1016/j.rx.2014.02.003

Source DB:  PubMed          Journal:  Radiologia        ISSN: 0033-8338


  2 in total

1.  Asymptomatic contrast medium extravasation.

Authors:  Yoh Arita; Shouta Bun; Takatsugu Segawa; Shinji Hasegawa
Journal:  BMJ Case Rep       Date:  2017-11-12

2.  Two Small Intravenous Catheters for High-Rate Contrast Medium Injection for Computed Tomography in Patients Lacking Superficial Veins to Accommodate a Large Catheter.

Authors:  Bum Gu Son; Min Jung Kim; Myeung Hwa Park; Kyoungsook Kim; Jiyu Kim; Se-Young Kim; Kyung Jin Lee; Sang Hyun Choi; Ah Young Kim; Seong Ho Park
Journal:  Korean J Radiol       Date:  2018-04-06       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.